EVIDENTIQ Trademark

Trademark Overview

On Monday, August 9, 2021, a trademark application was filed for EVIDENTIQ with the United States Patent and Trademark Office. The USPTO has given the EVIDENTIQ trademark a serial number of 79332616. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 20, 2024. This trademark is owned by EvidentIQ Group GmbH. The EVIDENTIQ trademark is filed in the Advertising, Business and Retail Services category with the following description:

Arranging of test persons for medical trials, namely, recruitment advertisement services, namely, posting of clinical trial notices for the purposes of recruiting patients for participation in medical trials
evidentiq

General Information

Serial Number79332616
Word MarkEVIDENTIQ
Filing DateMonday, August 9, 2021
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, March 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Pseudo MarkEVIDENT IQ
Goods and ServicesArranging of test persons for medical trials, namely, recruitment advertisement services, namely, posting of clinical trial notices for the purposes of recruiting patients for participation in medical trials

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, February 4, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvidentIQ Group GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 10, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 20, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 20, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 20, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 6, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 6, 2023FINAL REFUSAL E-MAILED
Wednesday, September 6, 2023FINAL REFUSAL WRITTEN
Thursday, August 3, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, July 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 18, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 18, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, January 18, 2023SUSPENSION LETTER WRITTEN
Tuesday, November 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 22, 2022REFUSAL PROCESSED BY IB
Saturday, May 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, May 28, 2022REFUSAL PROCESSED BY MPU
Friday, May 20, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 19, 2022NON-FINAL ACTION WRITTEN
Monday, May 9, 2022ASSIGNED TO EXAMINER
Tuesday, February 8, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

evidentiq namely medical trials notices trial purposes recruiting clinical participation patients